Overview Fundamentals API Earnings EOD API Sample Code Pricing

Ignyte Acquisition Corp (PKBO NASDAQ) stock market data APIs

$0.14 0(0%) as of September 6, 2024
Price chart is built with Anychart

Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of patients with cancer, inflammatory, and rare diseases in the United States. The company's lead product candidate is PHP-303, which is in Phase 2 clinical study for the treatment of alpha-1 antitrypsin deficiency and acute respiratory distress syndrome. It also develops Trop2 PH1, an antibody-drug-conjugate in preclinical trials for solid tumors. Peak Bio, Inc. is based in Pleasanton, California.

Ignyte Acquisition Corp Financial Data Overview

0.14
0.14
-
0.14
0.14
0.002-0.43
3 237 K
23 125 K
354 K
-0.0899
0.223
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PKBO',
Type: 'Common Stock',
Name: 'Ignyte Acquisition Corp',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00YVT9720',
ISIN: NULL,
CUSIP: NULL,
CIK: '1834645',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-03-15',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Ignyte Acquisition Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 354 K
  • EBITDA -6 652 362
  • Earnings Per Share -0.18
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Ignyte Acquisition Corp Earnings via APIs

  • Latest Release 2024-08-28
  • EPS/Forecast NaN

Get Ignyte Acquisition Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com